Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28884
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, H.-
dc.contributor.authorBrandes, D.-
dc.contributor.authorCarraro, M.-
dc.contributor.authorComi, G.-
dc.contributor.authorMao-Draayer, Y.-
dc.contributor.authorIzquierdo, G.-
dc.contributor.authorKim, H. -J.-
dc.contributor.authorMeuth, S.-
dc.contributor.authorPardo, G.-
dc.contributor.authorSharrack, B.-
dc.contributor.authorTornatore, C.-
dc.contributor.authorZiemssen, T.-
dc.contributor.authorJacobs, Alessia-
dc.contributor.authorChung, L.-
dc.contributor.authorDaizadeh, N.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.date.accessioned2019-08-06T08:55:04Z-
dc.date.available2019-08-06T08:55:04Z-
dc.date.issued2018-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 24(2), p. 468-469-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/28884-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleNo correlation between lymphocyte pharmacodynamics and autoimmune adverse events following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 10-12, 2018-
local.bibliographicCitation.conferencename34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-
local.bibliographicCitation.conferenceplaceBerlin, GERMANY-
dc.identifier.epage469-
dc.identifier.issue2-
dc.identifier.spage468-
dc.identifier.volume24-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Wiendl, H.; Meuth, S.] Univ Munster, Munster, Germany. [Brandes, D.] Hope MS Ctr, Knoxville, TN USA. [Carraro, M.] Novant Hlth, Charlotte, NC USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Mao-Draayer, Y.] Univ Michigan, Sch Med, Ann Arbor, MI USA. [Izquierdo, G.] Virgen Macarena Univ Hosp, Seville, Spain. [Kim, H. -J.] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea. [Pardo, G.] Oklahoma Med Res Fdn, OMRF Multiple Sclerosis Ctr Excellence, 825 NE 13th St, Oklahoma City, OK 73104 USA. [Sharrack, B.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Tornatore, C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA. [Ziemssen, T.] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany. [Jacobs, A.; Chung, L.; Daizadeh, N.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, Rehabil & MS Ctr Overpelt, BIOMED, Hasselt, Belgium.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000446861401230-
item.fulltextWith Fulltext-
item.contributorWiendl, H.-
item.contributorBrandes, D.-
item.contributorCarraro, M.-
item.contributorComi, G.-
item.contributorMao-Draayer, Y.-
item.contributorIzquierdo, G.-
item.contributorKim, H. -J.-
item.contributorMeuth, S.-
item.contributorPardo, G.-
item.contributorSharrack, B.-
item.contributorTornatore, C.-
item.contributorZiemssen, T.-
item.contributorJacobs, Alessia-
item.contributorChung, L.-
item.contributorDaizadeh, N.-
item.contributorVAN WIJMEERSCH, Bart-
item.fullcitationWiendl, H.; Brandes, D.; Carraro, M.; Comi, G.; Mao-Draayer, Y.; Izquierdo, G.; Kim, H. -J.; Meuth, S.; Pardo, G.; Sharrack, B.; Tornatore, C.; Ziemssen, T.; Jacobs, Alessia; Chung, L.; Daizadeh, N. & VAN WIJMEERSCH, Bart (2018) No correlation between lymphocyte pharmacodynamics and autoimmune adverse events following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis. In: MULTIPLE SCLEROSIS JOURNAL, 24(2), p. 468-469.-
item.accessRightsRestricted Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Poster Session 2.pdf
  Restricted Access		Published version82.59 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.